I'm starting to wonder why you seem to have such a fascination with cold cuts...
As a more serious topic, you seem to be pro-Trixie and anti-Titan. I can understand that you are more vocal about your disappointment in Titan's PPS than most, but you seem to be attempting to besmirch the technology with these "deli slicer" references. Do you honestly believe that Trixie has a superior technology to Titan's? The robotics market seems to be supporting the notion that Senhance and its European predecessor don't have much large-scale marketability, given the extremely limited number of system sales for a technology that has been commercially available since 2012. Haptic feedback was on Amadeus and Titan still has the technology in their portfolio, but surgeons indicated that they felt it wasn't worth pursuing in an advanced platform. The eye-chasing camera is a novel technology but with very limited usefulness during a surgical procedure. I don't understand why you seem to find SPORT so comical when you are supporting a device that is proving its undesirability with every week that passes without a sale.
I actually want Trixie to sell some systems in order to validate the marketplace as being able to support a viable alternative to ISRG. Trixie's success in system sales would be a huge relief to all imminent newcomers to surgical robotics. For some reason, that is not happening.
Please tell us all WHY Senhance is better than SPORT.
Message in reply to:
cfo wasn't in need for a deli slicer
